These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6433008)

  • 21. Plasma hormones and pituitary luteinizing hormone in the rat during the early stages of pregnancy and after post-coital treatment with tamoxifen (ICI 46,474).
    Watson J; Anderson FB; Alam M; O'Grady JE; Heald PJ
    J Endocrinol; 1975 Apr; 65(1):7-17. PubMed ID: 1141814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the subcutaneous and intranasal administration of an LH-RH antagonist ([N-Ac-D-p-Cl-Phe1,2,D-Trp3,D-Arg6,D-Ala10]-LH-RH) in the rhesus monkey.
    Asch RH; Balmaceda JP; Neves de Castro M; Schally AV
    Adv Contracept; 1985 Jun; 1(2):109-17. PubMed ID: 3939508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intranasal gonadotropin-releasing hormone agonist as a contraceptive agent.
    Bergquist C; Nillius SJ; Wide L
    Lancet; 1979 Aug; 2(8136):215-7. PubMed ID: 89330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hormonal and clinical efficacy of (D-Leu6)-des Gly-NH2(10)-LH.RH ethylamide against prostatic cancer].
    Imai K; Kumasaka F; Kobayashi M; Suzuki T; Takahashi O; Yamanaka H
    Hinyokika Kiyo; 1985 Dec; 31(12):2302-6. PubMed ID: 2938456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pituitary function, ovarian follicular growth, and plasma concentrations of 17 beta-estradiol and progesterone in prepubertal heifers during and after treatment with the luteinizing hormone-releasing hormone agonist deslorelin.
    Bergfeld EG; D'Occhio MJ; Kinder JE
    Biol Reprod; 1996 Apr; 54(4):776-82. PubMed ID: 8924496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of endopeptidase 24.15 greatly increases the release of luteinizing hormone and follicle stimulating hormone in response to luteinizing hormone/releasing hormone.
    Lasdun A; Orlowski M
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1265-71. PubMed ID: 2113581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fourteen-day versus twenty-one-day regimens of intermittent intranasal luteinizing hormone-releasing hormone agonist combined with an oral progestogen as antiovulatory contraceptive approach.
    Lemay A; Faure N
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1379-85. PubMed ID: 2946711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
    Welschen R; Osman P; Dullaart J; de Greef WJ; Uilenbroek JT; de Jong FH
    J Endocrinol; 1975 Jan; 64(1):37-47. PubMed ID: 1167896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of intranasal administration of LHRH superanalogue on endogenous LHRH and gonadotropins in humans].
    Matsubara M
    Nihon Naibunpi Gakkai Zasshi; 1986 Aug; 62(8):837-42. PubMed ID: 3096798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of (D-Leu6)-des Gly-NH2 10-LHRH ethylamide against prostatic cancer.
    Yamanaka H; Makino T; Yajima H; Saruki K; Shida K
    Prostate; 1985; 6(1):27-34. PubMed ID: 3918298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of estrogen and progesterone on the functional capacity of the gonadotrophs.
    Lasley BL; Wang CF; Yen SS
    J Clin Endocrinol Metab; 1975 Nov; 41(5):820-6. PubMed ID: 1102551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gonadotropin-releasing hormone agonist suppresses ovulation, menses, and endometriosis in monkeys: an individualized, intermittent regimen.
    Werlin LB; Hodgen GD
    J Clin Endocrinol Metab; 1983 Apr; 56(4):844-8. PubMed ID: 6403565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Administration of GnRH at estrus influences pregnancy rates, serum concentrations of LH, FSH, estradiol-17 beta, pregnancy-specific protein B, and progesterone, proportion of luteal cell types, and in vitro production of progesterone in dairy cows.
    Mee MO; Stevenson JS; Alexander BM; Sasser RG
    J Anim Sci; 1993 Jan; 71(1):185-98. PubMed ID: 8454542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blockade of LH and FSH secretion by LH-releasing hormone, by the LH-releasing hormone analogue, buserelin, and by combined treatment with LH-releasing hormone and oestradiol benzoate.
    Schuiling GA; Pols-Valkhof N; van der Schaaf-Verdonk GC; Koiter TR
    J Endocrinol; 1984 Dec; 103(3):301-9. PubMed ID: 6438265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization.
    Droesch K; Muasher SJ; Brzyski RG; Jones GS; Simonetti S; Liu HC; Rosenwaks Z
    Fertil Steril; 1989 Feb; 51(2):292-7. PubMed ID: 2492234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypothalamus-pituitary-ovarian axis in cyclic rats lacking progesterone actions.
    Sánchez-Criado JE; Galiot F; Bellido C; Gonzalez D; Tébar M
    Biol Reprod; 1993 Apr; 48(4):916-25. PubMed ID: 8485257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Androgen selectively stimulates follicle-stimulating hormone-beta mRNA levels after gonadotropin-releasing hormone antagonist administration.
    Wierman ME; Wang C
    Biol Reprod; 1990 Mar; 42(3):563-71. PubMed ID: 2111188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of chronic D-Leu6, des-Gly10-gonadotropin releasing hormone ethylamide on male sex tissues.
    Rajfer J; Heber D; Peng S; Swerdloff RS
    Biol Reprod; 1984 Apr; 30(3):646-51. PubMed ID: 6426536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Failure of positive feedback of oestradiol during chronic intranasal luteinizing hormone-releasing hormone agonist treatment.
    Bergquist C; Nillius SJ; Wide L
    Clin Endocrinol (Oxf); 1982 Feb; 16(2):147-51. PubMed ID: 6802530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
    Fraser HM; Nestor JJ; Vickery BH
    Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.